Ray Amrit (CIK 1924797) reported 4 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-06-12). Recent activity: Buy FTRE (38,817 shares), Buy RARE (7,751 shares), Buy RARE (5,740 shares), Buy FTRE (7,282 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Fortrea Holdings Inc. (FTRE) | Director | Buy | 38,817 | $0 |
| 2026-05-18 | Ultragenyx Pharmaceutical Inc. (RARE) | Director | Buy | 7,751 | $0 |
| 2025-05-19 | Ultragenyx Pharmaceutical Inc. (RARE) | Director | Buy | 5,740 | $0 |
| 2025-05-16 | Fortrea Holdings Inc. (FTRE) | Director | Buy | 7,282 | $0 |
Source: SEC Form 4 filings · as of 2026-06-12